Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A combination of eyelid pressure patching and decellularized, dehydrated pure amniotic membrane basement membrane healed ...

Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that ...

From dry eyes to infections and irritation, here’s what misuse of eye makeup and contact lenses can do to your eyes.

DT-168 is a GeneTAC® small molecule, formulated as an eye drop, that is designed to ... “FECD is a progressive corneal disease with no disease-modifying treatments currently available ...

Tommy Pham was diagnosed with a progressive degenerative eye disease in 2008, six years before he made his major league debut ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Discover surprising truths about blindness, from the spectrum of visual impairment to revolutionary treatments and adaptive ...

Glaukos Corp., the most valuable public company in Orange County’s thriving ophthalmology sector, appears to be expanding its ...

an implant for eyesight-robbing disease wet age-related macular degeneration (AMD) that gives patients an alternative to regular injections into the eye. Susvimo has the same active ingredient as ...

CARLSBAD, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, ...